ArticleTranslational lung cancer research2018

Durvalumab for non-resectable stage IIIB non-small cell lung cancer-a small step or a big leap?

Wolfram C M Dempke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.